US2457405A
(en)
|
1945-09-25 |
1948-12-28 |
Monsanto Chemicals |
Halo nitroparaffin modified aminoplasts
|
US3261828A
(en)
|
1962-10-04 |
1966-07-19 |
Hoffmann La Roche |
3h-1,4-benzodiazepine-2,5(1h,4h)-dione compounds
|
US3384635A
(en)
|
1966-09-28 |
1968-05-21 |
Sterling Drug Inc |
1, 4-benzodiazepine derivatives
|
US3415814A
(en)
|
1966-09-28 |
1968-12-10 |
Sterling Drug Inc |
4-(cyclopropylmethyl)-3h-1,4-benzodiazepine-2,5(1h,4h)-dione
|
AT280290B
(de)
|
1967-11-24 |
1970-04-10 |
Boehringer Sohn Ingelheim |
Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen
|
USRE30293E
(en)
*
|
1969-03-18 |
1980-06-03 |
Knoll A.G. |
Process for preparing 1,5-benzodiazepine-2-ones
|
US4108852A
(en)
|
1969-03-18 |
1978-08-22 |
Knoll Ag. |
Process for preparing 1,5-benzodiazepine-2-ones
|
GB1324469A
(en)
|
1970-10-28 |
1973-07-25 |
Knoll Ag |
Derivatives of benzodiazepines
|
ZA7467B
(en)
|
1973-01-16 |
1974-11-27 |
J Voorhees |
Compositions and treatment of proliferative skin diseases with b2 agonists
|
IE38931B1
(en)
|
1973-03-09 |
1978-07-05 |
Lipha |
Triazolobenzodiazepines
|
US4076823A
(en)
|
1977-08-18 |
1978-02-28 |
E. R. Squibb & Sons, Inc. |
Triazolo-2,4-benzodiazepines
|
US4495101A
(en)
|
1983-04-28 |
1985-01-22 |
American Home Products Corporation |
Antiinflammatory 5H-tetrazolo (5,1-c)(1,4)benzodiazepine derivatives
|
US4551480A
(en)
|
1983-06-21 |
1985-11-05 |
Stiefel Laboratories, Inc. |
Compositions for the treatment of psoriasis
|
US4894366A
(en)
|
1984-12-03 |
1990-01-16 |
Fujisawa Pharmaceutical Company, Ltd. |
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
|
US4820834A
(en)
|
1984-06-26 |
1989-04-11 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
FR2591596B1
(fr)
|
1985-12-13 |
1988-09-09 |
Roussel Uclaf |
Nouvelles 4h-triazolo(4,3-a)(1,4)benzodiazepines, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
|
GB8608080D0
(en)
|
1986-04-02 |
1986-05-08 |
Fujisawa Pharmaceutical Co |
Solid dispersion composition
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US4751223A
(en)
|
1986-10-14 |
1988-06-14 |
Hoechst-Roussel Pharmaceuticals, Inc. |
Antiinflammatory and analgesic aminoalkyl tetracyclic benzodiazepines
|
US4898861A
(en)
|
1987-03-26 |
1990-02-06 |
Hoffmann-La Roche Inc. |
Method for inhibiting the proliferation of tumor cells
|
US4970207A
(en)
|
1988-07-07 |
1990-11-13 |
Fujisawa Pharmaceutical Company, Ltd. |
Benzodiazepine derivatives
|
SE8804074D0
(sv)
|
1988-11-10 |
1988-11-10 |
Pharmacia Ab |
Sensorenhet och dess anvaendning i biosensorsystem
|
WO1990013332A1
(en)
|
1989-05-11 |
1990-11-15 |
Cedars-Sinai Medical Center |
Stent with sustained drug delivery
|
US5258510A
(en)
|
1989-10-20 |
1993-11-02 |
Otsuka Pharma Co Ltd |
Benzoheterocyclic compounds
|
US5041438A
(en)
|
1989-10-30 |
1991-08-20 |
Hoffmann-La Roche Inc. |
Method for treating retroviral infections with benzodiazepine compounds
|
US5324726A
(en)
|
1989-12-18 |
1994-06-28 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
EP0470246B1
(en)
|
1990-02-28 |
1995-06-28 |
Medtronic, Inc. |
Intralumenal drug eluting prosthesis
|
US5217591A
(en)
|
1990-05-14 |
1993-06-08 |
Labintelligence, Inc. |
Gel electrophoresis sample applicator/retriever
|
ATE145208T1
(de)
|
1990-07-06 |
1996-11-15 |
Yoshitomi Pharmaceutical |
Kondensierte thiophenverbindungen und deren verwendung
|
GB9015879D0
(en)
|
1990-07-19 |
1990-09-05 |
Fujisawa Pharmaceutical Co |
Benzodiazepine derivatives
|
BR9200951A
(pt)
|
1991-03-21 |
1992-11-17 |
Hoffmann La Roche |
Compostos, processo para sua producao,preparacoes farmaceuticas e uso
|
CA2130195A1
(en)
|
1992-03-16 |
1993-09-30 |
Mark Gary Bock |
Benzodiazepine derivatives, compositions containing them and their use in therapy
|
US5599352A
(en)
|
1992-03-19 |
1997-02-04 |
Medtronic, Inc. |
Method of making a drug eluting stent
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
GB9307527D0
(en)
*
|
1993-04-13 |
1993-06-02 |
Fujisawa Pharmaceutical Co |
New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US5444092A
(en)
|
1994-07-20 |
1995-08-22 |
Collins; Jerry |
Method and composition for treating psoriasis
|
EP0804425A2
(en)
|
1994-07-29 |
1997-11-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzodiazepine derivatives
|
EP0776203A4
(en)
|
1994-08-18 |
1997-12-29 |
Merck & Co Inc |
N-2,3-DIHYDRO-1- (2-PROPYL) -2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPINE
|
US5618792A
(en)
|
1994-11-21 |
1997-04-08 |
Cortech, Inc. |
Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
|
US5677282A
(en)
*
|
1995-06-07 |
1997-10-14 |
Proscript, Inc. |
Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase
|
US5962337A
(en)
|
1995-06-29 |
1999-10-05 |
Pharmacopeia, Inc. |
Combinatorial 1,4-benzodiazepin-2,5-dione library
|
RU2096044C1
(ru)
|
1995-07-19 |
1997-11-20 |
Малое предприятие "Ветта" |
Ветеринарный имплантируемый препарат для регулирования биологического ритма животных
|
US5776946A
(en)
|
1995-08-28 |
1998-07-07 |
Mcgeer; Patrick L. |
Peripheral benzodiazepine receptor ligands as antiinflammatory agents
|
JP2001520636A
(ja)
|
1995-08-30 |
2001-10-30 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
慢性炎症性疾患における細胞蓄積の治療
|
US6579854B1
(en)
|
1996-08-14 |
2003-06-17 |
Vanderbilt University |
Diagnosis and management of infection caused by chlamydia
|
CN1130351C
(zh)
*
|
1996-12-10 |
2003-12-10 |
泽里新药工业株式会社 |
1,5-苯并二氮杂䓬衍生物
|
AU7799598A
(en)
|
1997-06-09 |
1998-12-30 |
Hoeffer Pharmacia Biotech, Inc. |
Device for rehydration and electrophoresis of gel strips and method of using thesame
|
US6074859A
(en)
|
1997-07-08 |
2000-06-13 |
Kikkoman Corporation |
Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein
|
US6080568A
(en)
|
1997-08-19 |
2000-06-27 |
Genencor International, Inc. |
Mutant α-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus licheniformis
|
KR100585348B1
(ko)
|
1997-10-08 |
2006-06-01 |
이소테크니카 인코포레이티드 |
중수소화된 시클로스포린 유사체 및 면역조절제로서 그의용도
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
FR2772271B1
(fr)
*
|
1997-12-11 |
2000-09-01 |
Union Pharma Scient Appl |
Nouvelle association pharmaceutique a activite analgesique
|
US6206914B1
(en)
|
1998-04-30 |
2001-03-27 |
Medtronic, Inc. |
Implantable system with drug-eluting cells for on-demand local drug delivery
|
WO1999058117A1
(fr)
|
1998-05-13 |
1999-11-18 |
Sanofi-Synthelabo |
Utilisation de composes reduisant l'apoptose
|
FR2779963A1
(fr)
|
1998-06-22 |
1999-12-24 |
Centre Nat Rech Scient |
Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer
|
HRP990246A2
(en)
*
|
1998-08-07 |
2000-06-30 |
Du Pont Pharm Co |
Succinoylamino benzodiazepines as inhibitors of a beta protein production
|
US6277844B1
(en)
|
1998-09-14 |
2001-08-21 |
Sydney Spector |
Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
|
US20030044776A1
(en)
|
1998-09-25 |
2003-03-06 |
James A. Dykens |
Compositions and methods for identifying agents that alter mitochondrial permeability transition pores
|
GB9823873D0
(en)
*
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
FR2785803B1
(fr)
|
1998-11-17 |
2005-03-25 |
Sanofi Sa |
Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes
|
US7175953B2
(en)
*
|
1999-04-09 |
2007-02-13 |
Institute Fuer Diagnostik Forschung |
Short-warp peptide-dye conjugate as contrast agent for optical diagnostic
|
US20050113460A1
(en)
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US7144880B2
(en)
|
1999-04-30 |
2006-12-05 |
Regents Of The University Of Michigan |
Compositions relating to novel compounds and targets thereof
|
US20040176358A1
(en)
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
JP5127096B2
(ja)
|
1999-04-30 |
2013-01-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
アポトーシスにより誘導される自己免疫疾患を処置するためのベンゾジアゼピンの使用
|
US20030119029A1
(en)
|
1999-04-30 |
2003-06-26 |
Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
|
US7276348B2
(en)
|
1999-04-30 |
2007-10-02 |
Regents Of The University Of Michigan |
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
|
US20060025388A1
(en)
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
AU5826100A
(en)
|
1999-07-13 |
2001-01-30 |
F. Hoffmann-La Roche Ag |
Benzazepinones and quinazolines
|
US6524623B1
(en)
|
1999-11-12 |
2003-02-25 |
Milton Hodosh |
Therapeutic compositions and methods of use thereof
|
EP1280559B1
(en)
|
2000-05-11 |
2006-03-08 |
Eastman Chemical Company |
Acylated cyclodextrin guest inclusion complexes
|
US20020048566A1
(en)
|
2000-09-14 |
2002-04-25 |
El-Deiry Wafik S. |
Modulation of cellular apoptosis and methods for treating cancer
|
US20020128208A1
(en)
|
2000-12-15 |
2002-09-12 |
Snyder James P. |
Nonpeptide agonists and antagonists of vasopressin receptors
|
CA2457405A1
(en)
|
2001-08-15 |
2003-02-27 |
The Regents Of The University Of Michigan |
Compositions and methods relating to benzodiazepine compounds
|
US7060705B2
(en)
*
|
2001-11-07 |
2006-06-13 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
AU2002357043B2
(en)
*
|
2001-12-06 |
2008-04-24 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
EP1450901A4
(en)
|
2001-12-10 |
2005-05-25 |
Bristol Myers Squibb Co |
(1-PHENYL-2-HETEROARYL) ETHYL-GUANIDINE COMPOUNDS AS AN INHIBITORS OF MITOCHONDRIAL F1F0 ATP HYDROLASE
|
WO2003106628A2
(en)
|
2002-06-17 |
2003-12-24 |
Bristol-Myers Squibb Company |
Benzodiazepine inhibitors of mitochondial f1f0 atp hydrolase and methods of inhibiting f1f0 atp hydrolase
|
US20040087489A1
(en)
|
2002-11-06 |
2004-05-06 |
Antonio Ruiz |
Compositions and methods for the treatment of mycobacterial infections
|
MXPA05005895A
(es)
|
2002-12-03 |
2006-02-08 |
Vela Pharmaceuticals Inc |
Composicion farmaceutica de 1-(3, 4-dimetoxifenil)-4 -metil-5-etil -7-metoxi-8 -hidroxi- 5h-2, 3-benzodiacepina y usos de la misma.
|
WO2005004988A2
(en)
|
2003-05-01 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US20050272723A1
(en)
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
US20060052369A1
(en)
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
AU2006203946B2
(en)
|
2005-01-03 |
2009-07-23 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US20070043033A1
(en)
|
2005-06-01 |
2007-02-22 |
The Regents Of The University Of Michigan |
Unsolvated benzodiazepine compositions and methods
|
US20070105844A1
(en)
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
NZ568254A
(en)
|
2005-11-01 |
2011-06-30 |
Univ Michigan |
1,4-Benzodiazepine-2,5-diones for regulating cell death and treating autoimmune diseases
|
US7759338B2
(en)
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|